New hope for kids with hard-to-treat leukemia: experimental combo shows promise
NCT ID NCT01279096
First seen Apr 26, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This early-phase study tested a new combination of chemotherapy drugs, including clofarabine, in 20 children and young adults whose acute lymphoblastic leukemia had returned or did not respond to initial treatment. The goal was to find the safest dose and see if the combination could help achieve remission. The study focused on high-risk patients, including those who had already had a stem cell transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOID LEUKEMIA RELAPSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Besançon University Hospital
Besançon, 25000, France
-
Lille University Hospital
Lille, 59037, France
Conditions
Explore the condition pages connected to this study.